Wieslander A - Search Results

1

Glucose degradation products result in cardiovascular toxicity in a rat model of renal failure.

Müller-Krebs S, Kihm LP, Zeier B, Gross ML, Wieslander A, Haug U, Zeier M, Schwenger V. Müller-Krebs S, et al. Among authors: wieslander a. Perit Dial Int. 2010 Jan-Feb;30(1):35-40. doi: 10.3747/pdi.2009.00031. Perit Dial Int. 2010. PMID: 20056977

2

Renal toxicity mediated by glucose degradation products in a rat model of advanced renal failure.

Müller-Krebs S, Kihm LP, Zeier B, Gross ML, Deppisch R, Wieslander A, Henle T, Penndorf I, Oh J, Reiser J, Nawroth PP, Zeier M, Schwenger V. Müller-Krebs S, et al. Among authors: wieslander a. Eur J Clin Invest. 2008 May;38(5):296-305. doi: 10.1111/j.1365-2362.2008.01945.x. Epub 2008 Mar 16. Eur J Clin Invest. 2008. PMID: 18346151

3

Biocompatibility of peritoneal dialysis fluids: long-term exposure of nonuremic rats.

Musi B, Braide M, Carlsson O, Wieslander A, Albrektsson A, Ketteler M, Westenfeld R, Floege J, Rippe B. Musi B, et al. Among authors: wieslander a. Perit Dial Int. 2004 Jan-Feb;24(1):37-47. Perit Dial Int. 2004. PMID: 15104335

4

Effects of acidity, glucose degradation products, and dialysis fluid buffer choice on peritoneal solute and fluid transport in rats.

Musi B, Carlsson O, Rippe A, Wieslander A, Rippe B. Musi B, et al. Among authors: wieslander a. Perit Dial Int. 1998 May-Jun;18(3):303-10. Perit Dial Int. 1998. PMID: 9663895

5

Glucose degradation products in peritoneal dialysis fluids may have both local and systemic effects: a study of residual fluid and mesothelial cells.

Linden T, Musi B, Järkelid L, Forsbäck G, Kjellstrand P, Deppisch R, Wieslander A. Linden T, et al. Among authors: wieslander a. Perit Dial Int. 2001 Nov-Dec;21(6):607-10. Perit Dial Int. 2001. PMID: 11783771

6

Glucose degradation and cytotoxicity in PD fluids.

Wieslander A, Lindén T. Wieslander A, et al. Perit Dial Int. 1996;16 Suppl 1:S114-8. Perit Dial Int. 1996. PMID: 8728175 No abstract available.

7

Clinical and physiological effects of a new, less toxic and less acidic fluid for peritoneal dialysis.

Rippe B, Simonsen O, Wieslander A, Landgren C. Rippe B, et al. Among authors: wieslander a. Perit Dial Int. 1997 Jan-Feb;17(1):27-34. Perit Dial Int. 1997. PMID: 9068019

8

Biologic significance of reduced levels of glucose degradation products.

Rippe B, Wieslander A. Rippe B, et al. Among authors: wieslander a. Perit Dial Int. 2001;21 Suppl 3:S114-8. Perit Dial Int. 2001. PMID: 11887804 Clinical Trial. No abstract available.

9

How to avoid glucose degradation products in peritoneal dialysis fluids.

Erixon M, Wieslander A, Lindén T, Carlsson O, Forsbäck G, Svensson E, Jönsson JA, Kjellstrand P. Erixon M, et al. Among authors: wieslander a. Perit Dial Int. 2006 Jul-Aug;26(4):490-7. Perit Dial Int. 2006. PMID: 16881345

10

Infusion fluids contain harmful glucose degradation products.

Bryland A, Broman M, Erixon M, Klarin B, Lindén T, Friberg H, Wieslander A, Kjellstrand P, Ronco C, Carlsson O, Godaly G. Bryland A, et al. Among authors: wieslander a. Intensive Care Med. 2010 Jul;36(7):1213-20. doi: 10.1007/s00134-010-1873-x. Epub 2010 Apr 16. Intensive Care Med. 2010. PMID: 20397009 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters